Scientist Explains the Longevity Genes That Help You Live Longer

Too Long; Didn't Watch — Summary

This video delves into the intricate relationship between genetics and longevity, analyzing the unique genetic profile of a 117-year-old woman, discussing the roles of genes like FOXO3 and IGF-1 in aging and resilience, and exploring the ethical and practical implications of gene editing and personalized supplement choices based on individual genetic predispositions.

Main Takeaways

• The longevity of supercentenarians like the 117-year-old woman is influenced by a complex interplay of beneficial and seemingly detrimental genes, highlighting the role of compensatory mechanisms and luck.
• Genes such as FOXO3 contribute significantly to stress resilience and immune function, acting as key transcription factors that can be modulated by lifestyle interventions like fasting and cold exposure.
• The balance of anabolic pathways, particularly IGF-1 and mTOR, is crucial for longevity, with lower activity often correlating with extended lifespan, though this must be balanced with muscle maintenance.
• Gene editing, while promising for enhancing longevity-related genes like FOXO3, presents significant ethical dilemmas and potential off-target effects that require careful consideration.
• Indiscriminate use of telomerase activators or growth hormone therapy can be risky, especially for individuals with underlying cancer risks or specific genetic predispositions, emphasizing the need for personalized approaches.
• Understanding one's genetic profile, including genes like APOE4 and those affecting neurotransmitter metabolism, is essential for tailoring lifestyle choices and supplement regimens to optimize health and longevity.

Detailed Summary

Introduction (0:00 - 0:48)

The discussion opens by acknowledging the previous episode's popularity, which focused on genetics influencing reactions to supplements and foods. The hosts introduce the topic of longevity genetics, specifically a recent study on the longest-living woman at the time, who passed away at 117.

The Genetics of a 117-Year-Old Woman (0:48 - 8:16)

• The study on the 117-year-old woman utilized a multi-omics approach, layering different biological studies like genomics, transcriptomics, and proteomics to understand her unique biology.
• Despite having some genes associated with shorter longevity and increased cancer risk, she lived an exceptionally long life, suggesting a complex interplay of genetics and environmental factors, including an element of luck.
• Surprisingly, she had short telomeres, which are typically considered markers of aging, but this might have protected her against cancer by limiting the growth of potential cancer cells.
• Her immune system was thought to be hyper-functioning due to mutations in cell adhesion molecules, enabling efficient detection and destruction of cancer cells.
• Mutations in MAP kinase, a signaling molecule for mTOR, potentially made anabolism more difficult but contributed to her longevity by reducing growth-promoting pathways.

Resilience, Immunity, and Longevity (8:16 - 14:33)

• Certain genes, like FOXO3, are associated with longevity by strengthening the immune system and overall resilience.
• FOXO3 acts as a transcription factor, changing cell behavior and interacting with mTOR and IGF-1 signaling.
• High IGF-1 and growth factors can suppress FOXO3 and activate mTOR, highlighting a delicate balance between anabolism and longevity.
• The speaker shares personal anecdotes of having low IGF-1 levels and a strong immune system, despite a family history of shorter lifespans, illustrating the complex and individualized nature of genetic influence.

Muscle Building Genetics (14:33 - 19:33)

• Receptor mutations, such as those affecting IGF-1 or androgen receptors, can fundamentally alter how individuals respond to hormones and interpret lab results.
• The speaker speculates that a hypersensitive IGF-1 receptor might lead to feedback loops that lower circulating IGF-1 levels.
• Personal experience with easy muscle gain despite low IGF-1 suggests individual genetic variations in how the body processes and responds to growth signals.
• The speaker discusses his own FOXO3 gene copy and insulin sensitivity, noting that he thrives on moderate carbohydrate intake and is sensitive to MAO inhibitors found in many supplements.

FOXO3 and Stress Resilience (19:33 - 24:53)

• FOXO3 increases stress resilience, and its expression can be boosted by activities like fasting, exercise, and cold exposure.
• The question arises whether individuals with naturally higher FOXO3 expression benefit more from these stressors or if those with lower FOXO3 benefit more by restoring a deficit.
• The DBH gene, which converts dopamine to norepinephrine, is discussed; mutations can lead to higher dopamine and lower norepinephrine, impacting focus and impulsivity.
• Cold exposure significantly increases norepinephrine (500-700%) more than dopamine (200-300%), suggesting it's a key driver of cognitive benefits, especially for individuals with DBH mutations.

FOXO3 Gene Editing (24:53 - 32:08)

• A study on monkeys in China involved gene editing human stem cells to increase FOXO3 expression, leading to some improvements in biological age clocks and organ function.
• The speaker expresses skepticism about the precision of gene editing, citing personal experience with off-target effects in CRISPR experiments.
• Ethical concerns regarding gene editing are raised, particularly the line between treating clinical diseases and eugenics, as well as the long-term implications of altering germline cells.
• The controversial case of gene-edited twins in China, initially claimed to be HIV-immune but later suggested to be "super smart," highlights the complexities and potential hidden agendas in gene editing research.

Can Telomere Lengthening Be Harmful to Some Individuals (32:08 - 38:58)

• The discussion revisits the 117-year-old woman's short telomeres and the theory that they might have protected her from cancer, especially given her other cancer-risk genes.
• The potential for telomerase activators to promote existing cancer growth is a significant concern, as cancer cells can also utilize these nutrients.
• The speaker emphasizes the difficulty of definitively assessing cancer risk before taking supplements, as tumors need to be of a certain size to be detectable.
• Both speakers agree they would not opt for telomere gene therapy, even if deemed safe, due to the complex and not fully understood biology of aging and the potential for unintended consequences.
• The concept of an "arms race" between the immune system and evolving cancers is introduced, highlighting the dynamic nature of health and disease.

IGF-1 and Growth Hormone and Longevity (38:58 - 50:08)

• The speaker considers gene therapy to reduce IGF-1, but expresses concern about its impact on muscle building and training.
• The use of growth hormone therapy in longevity clinics is questioned, given that high growth hormone levels can negatively affect longevity.
• Personalized approaches to hormone therapy are advocated, where genetic testing can identify true genetic suppressions in hormone production (e.g., DHEA, testosterone, thyroid hormone) that lifestyle changes alone cannot fully address.
• The example of Lionel Messi, who received growth hormone for stunted growth, illustrates legitimate medical uses for such therapies in cases of severe genetic mutations.
• Individuals with Laron syndrome, characterized by extremely low IGF-1 and growth hormone from birth, exhibit remarkably low rates of cancer and diabetes, underscoring the link between these hormones and disease.
• The concept of "hormone partitioning" is introduced, suggesting that resistance training can direct IGF-1 towards muscle growth rather than cancer growth, potentially explaining why bodybuilders, despite high IGF-1, rarely die from cancer.

Genetically Short Sleepers (50:08 - 54:38)

• The topic shifts to individuals who genetically require less sleep, questioning whether this confers protection against the negative effects of sleep deprivation or simply means they can't sleep longer.
• Orexin signaling, which drives wakefulness, is mentioned as a potential factor, with mutations leading to lower orexin linked to narcolepsy.
• The speaker suggests that genetically short sleepers likely have both the inability to sleep long and protection against the negative effects, as they function normally on minimal sleep.
• A personal anecdote about a friend who thrives on 4-5 hours of sleep highlights the social challenges of having significantly more waking hours than others.
• The discussion touches on the broader implications of extended lifespan, questioning the desire for extreme longevity if loved ones are not on the same journey, emphasizing the importance of functional healthspan.

What You Should Know About Your Longevity Genes (54:38 - 1:00:21)

• Instead of focusing on specific "longevity genes" to test for, the speaker, as a pharmacologist, emphasizes using genetic information to personalize supplement choices.
• Many senolytics (e.g., quercetin, resveratrol) can affect neurotransmitter breakdown, potentially causing anxiety or sleep issues for individuals with specific genetic predispositions like slow MAO.
• Methylene blue, while beneficial for some, can be problematic for those with G6PD mutations, potentially acting as a prooxidant or causing anxiety.
• Genetic testing can identify individuals who might benefit from specific supplements (e.g., methylene blue for sluggish mitochondrial complexes 1 and 3) or those who should avoid certain compounds.
• The importance of understanding how supplements interact with individual genetics is stressed, as even high-quality supplements can have adverse effects if not aligned with one's genetic profile.
• The APOE4 gene is highlighted as a crucial gene to test for due to its strong link to longevity, Alzheimer's risk, and dietary patterns.
• The speaker, Tyler Panzner, encourages people to learn more about his work on Instagram, Facebook, LinkedIn, YouTube, TikTok, and his website, emphasizing his mission to make genetics more accessible and to help people understand how supplements interact with their unique genetic makeup.

Notable Quotes

"It's really layering on all these I like to think of them as chapters of a book, right, that layer on on top of each other."
— Tyler Panzner

"I feel like there's got to be a certain tipping point, right? Once you hit a certain age, it's like if those cancers haven't begun forming yet, the tieumirs can possibly limit how much they can grow."
— Tyler Panzner

"The thing with gene editing for me is I feel like we can't be as certain as some people make it to believe that those molecular scissors aren't cutting anywhere else."
— Tyler Panzner

"I always tell people, we're all chasing the perfect protocol, health optimization, but there's really no such thing as the perfect protocol."
— Tyler Panzner

"I think there's so much more that we don't know than we do know about health and science. And I think it's going to be that way for a very long time."
— Tyler Panzner

"If it doesn't line up with your genetics, you're not going to feel good on that."
— Tyler Panzner

"I've worked with people that, you know, aren't they don't seem to be these super graceful ages and they have the FOX03, right? Just confirming as well, you know, there's no one single longevity gene that guarantees these things, right?"
— Tyler Panzner